ACTIVE

BIOQUBE FACTORY FUND I

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-1,1 M €+39,0 %over 1 year
Gross margin-1,3 M €+46,9 %over 1 year
Equity67 M €+16,0 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

BIOQUBE FACTORY FUND I is a Limited partnership incorporated in 2020. Its registered office is in Bruxelles.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0747.784.678
Incorporation
02/06/2020
Legal form
Limited partnership
Registered office
Place des Barricades 13
1000 Bruxelles · BruxellesSee on map
Contributed capital
78 778 818,71 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Contacts
2 public details availableLog in to view
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin-1,3 M €-2,4 M €-2,4 M €-2,3 M €-4 M €
EBITDA-1,3 M €-2,4 M €-2,4 M €-2,3 M €-4 M €
Operating result-1,3 M €-2,4 M €-2,4 M €-2,3 M €-4 M €
Net result-1,1 M €-1,8 M €-2,4 M €-2,5 M €-4 M €
Balance sheet
Equity67 M €57,7 M €41,9 M €23,8 M €12,5 M €
Total assets68,3 M €59,9 M €42,5 M €24,5 M €13,3 M €
Cash10 M €4,9 M €4,1 M €2 M €5,1 M €
Debts1,3 M €2,1 M €584 k €665,4 k €12,3 k €
Other
Workforce0,0 ETP0,0 ETP–––

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

BIOQUBE VENTURES

Manager · since 29 mai 2020 · 0738.714.089

Represented by Dumont Debora

Active

Ended mandates

BIOQUBE VENTURES

Director · since 29 mai 2020 · 0738.714.089

Represented by Debora Dumont

Ended
BIOQUBE VENTURES

Manager · since 29 mai 2020 · 0738.714.089

Represented by Debora Dumont

Ended

Other companies at this address

Place des Barricades 13 1000 Bruxelles
CompanyCBE no.
ALBA HOLDING● Active
1038.846.046
ARMED CELL THERAPEUTICS● Active
1039.592.451
Bioqube Factory Fund II Partnership● Active
1016.717.178
Bioqube Factory Fund II Privak● Active
1016.385.497
Domein van Vorselaar● Active
0423.793.790
EDWIN VERMULST● Active
0862.424.030
Fibrocor Therapeutics Europe● Active
1025.566.152
MERISANT EUROPE● Active
0471.239.064
Orgues De Facto● Active
0763.798.685
PETER KUGEL● Active
0607.848.520
Société Coopérative pour le Développement Industriel en Afrique● Liquidation
0400.488.749
Société des Habitations à Bon Marché● Liquidation
0403.363.117
Stoffels IMC● Active
0780.918.294
VIPOWA● Active
0886.120.437
VVGB 2016● Active
0654.806.418
VVGB Advocaten fv● Active
0525.904.504

Full financial information

Source · NBB
20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202229/05/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months20 months
Filing date12/05/202628/04/202503/04/202413/04/202313/04/2022
General meeting27/03/202628/03/202529/03/202431/03/202325/03/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202527/03/202612/05/2026DutchPDF
Abridged model31/12/202428/03/202528/04/2025DutchPDF
Abridged model31/12/202329/03/202403/04/2024DutchPDF
Abridged model31/12/202231/03/202313/04/2023DutchPDF
Abridged model31/12/202125/03/202213/04/2022DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

BIOQUBE VENTURES

Manager · since 29 mai 2020 · 0738.714.089

Represented by Dumont Debora

Active

Ended mandates

BIOQUBE VENTURES

Director · since 29 mai 2020 · 0738.714.089

Represented by Debora Dumont

Ended
BIOQUBE VENTURES

Manager · since 29 mai 2020 · 0738.714.089

Represented by Debora Dumont

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares12/05/2026
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares09/04/2026
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other12/01/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates03/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares07/12/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - KAPITAAL - AANDELEN
    PDF
  • Capital / shares04/11/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - KAPITAAL - AANDELEN
    PDF
  • Capital / shares23/06/2021
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares08/06/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - KAPITAAL - AANDELEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 24/04/2026
    reduction_capital
  2. 26/03/2026
    reduction_capital
  3. 2025
    Annual accounts 2025-1,1 M €↑
  4. 2024
    Annual accounts 2024-1,8 M €↑
  5. 29/03/2024
    reconductionBDO Bedrijfsrevisoren BV — Commissaris
  6. 29/03/2024
    nominationGert Maris — wettelijke vertegenwoordiger
  7. 2024
    Name changeBioqube Factory Fund I 'private privak naar Belgisch recht'
  8. 2023
    Annual accounts 2023-2,4 M €↑
  9. 2022
    Annual accounts 2022-2,5 M €↑
  10. 2021
    Annual accounts 2021-4 M €
  11. 2021
    Name changeBioqube Factory Fund I
  12. 02/06/2020
    IncorporationLimited partnership